ImmuCell Corp (ICCC)
5.155
+0.04
(+0.88%)
USD |
NASDAQ |
May 08, 12:38
ImmuCell Price: 5.155 for May 8, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 07, 2024 | 5.09 | 5.185 | 5.00 | 5.11 | 10840.00 |
| May 06, 2024 | 5.17 | 5.21 | 5.04 | 5.09 | 29276.00 |
| May 03, 2024 | 5.02 | 5.15 | 5.00 | 5.03 | 5994.00 |
| May 02, 2024 | 5.03 | 5.045 | 4.985 | 5.00 | 10413.00 |
| May 01, 2024 | 5.11 | 5.16 | 5.00 | 5.00 | 28675.00 |
| Apr 30, 2024 | 5.13 | 5.13 | 4.91 | 4.91 | 18651.00 |
| Apr 29, 2024 | 5.20 | 5.20 | 5.06 | 5.10 | 9991.00 |
| Apr 26, 2024 | 5.10 | 5.14 | 5.10 | 5.14 | 1776.00 |
| Apr 25, 2024 | 5.13 | 5.13 | 5.03 | 5.10 | 6409.00 |
| Apr 24, 2024 | 5.056 | 5.06 | 4.82 | 5.04 | 7163.00 |
| Apr 23, 2024 | 5.03 | 5.03 | 5.03 | 5.03 | 0.000 |
| Apr 22, 2024 | 5.050 | 5.051 | 5.030 | 5.03 | 3262.00 |
| Apr 19, 2024 | 5.05 | 5.12 | 5.01 | 5.02 | 3187.00 |
| Apr 18, 2024 | 5.033 | 5.061 | 5.033 | 5.05 | 2492.00 |
| Apr 17, 2024 | 5.02 | 5.07 | 5.02 | 5.05 | 5926.00 |
| Apr 16, 2024 | 5.13 | 5.16 | 5.03 | 5.05 | 20001.00 |
| Apr 15, 2024 | 5.15 | 5.15 | 5.000 | 5.07 | 13136.00 |
| Apr 12, 2024 | 5.119 | 5.119 | 5.02 | 5.02 | 3144.00 |
| Apr 11, 2024 | 5.20 | 5.20 | 5.10 | 5.130 | 11974.00 |
| Apr 10, 2024 | 5.31 | 5.35 | 5.114 | 5.20 | 12865.00 |
| Apr 09, 2024 | 5.28 | 5.31 | 4.99 | 5.22 | 22494.00 |
| Apr 08, 2024 | 5.30 | 5.328 | 5.30 | 5.32 | 3057.00 |
| Apr 05, 2024 | 5.125 | 5.20 | 5.09 | 5.17 | 3159.00 |
| Apr 04, 2024 | 5.206 | 5.27 | 5.07 | 5.17 | 9063.00 |
| Apr 03, 2024 | 5.22 | 5.25 | 5.195 | 5.195 | 3857.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
3.79
Minimum
Mar 31 2020
11.88
Maximum
Feb 19 2021
6.719
Average
5.99
Median
May 23 2019
Price Benchmarks
| NovaBay Pharmaceuticals Inc | 0.087 |
| Palatin Technologies Inc | 2.09 |
| iBio Inc | 1.94 |
| Theriva Biologics Inc | 0.4178 |
| Oragenics Inc | 1.28 |
Price Related Metrics
| PS Ratio | 2.286 |
| PEG Ratio | -0.0484 |
| Price to Book Value | 1.599 |
| Earnings Yield | -14.55% |
| Market Cap | 39.96M |
| PEGY Ratio | -0.0484 |